June 24, 2020 07:31 AM EDT

UK Supreme Court strikes down Regeneron patents, opening door for Kymab

Jason Mast

Editor

The UK Supreme Court has struck down a pair of Regeneron patents, all but ending a legal dispute between the large US biotech and an …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

ENDPOINTS CAREERS

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA

view job offer post your job now

TRENDING NOW

Bristol Myers bets $1.5B on BioNTech's PD-L1xVEGF from Biotheus

Sanofi to snap up Blueprint Medicines and mastocytosis drug Ayvakit for $9.1B

Kymera unveils ‘exceptional’ Phase 1 data for its Dupixent-in-a-pill program

In race with Merus, Bicara makes the case for two-year survival data

Vera posts positive Phase 3 rare kidney disease data, but crowded market looms

sponsored

Cytiva and EurekaBio form strategic partnership to advance lentiviral vector manufacturing for cell and gene therapy ...